ClinicalTrials.gg
Sign In

Vasculitis clinical trials

The registry lists 170 studies for Vasculitis across more than 10 countries. 46 are recruiting or about to start. 40 of them are mainly about Vasculitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02. Counting its 15 narrower conditions too, such as Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: 824 studies, 263 open.

Get an email when these change. Save the Vasculitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
84
Recruiting
38
Status unknown
19
Terminated
8
Active, not recruiting
8
Not yet recruiting
6

Phase

Phase 2
38
Phase 3
25
Phase 1
17
Phase 4
5
Early Phase 1
1

Where

United States
69
France
33
United Kingdom
28
Canada
22
Germany
18
Italy
10

Who runs them

University of Pennsylvania (13) · Assistance Publique - Hôpitaux de Paris (13) · National Institute of Allergy and Infectious Diseases (NIAID) (11) · Amgen (10) · Cambridge University Hospitals NHS Foundation Trust (9) · University of Edinburgh (5) · Novartis Pharmaceuticals (3) · University of Bonn (3)

What is being tested here

Drugs under test in Vasculitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Infliximab315
Prednisone247
Rituximab237
Methotrexate216
Azathioprine215
Abatacept225
Belimumab213
Adalimumab202
Tocilizumab202
Mycophenolic Acid126

Drug classes tested here Antimetabolites 2 open · Corticosteroids 2 open

Coming up

5phase 3 studies under way
9studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 38 Vasculitis studies recruiting now, 31 (82%) set no upper age limit and 4 (11%) stop at 75 or younger. 12 (32%) take children under 18. 1 (3%) are for women only and 1 (3%) for men only; 6 (16%) take healthy volunteers.

Recruiting studies that take each age, of 38
AgeWomenMen
1011 (29%)11 (29%)
1835 (92%)34 (89%)
3033 (87%)32 (84%)
4033 (87%)32 (84%)
5034 (89%)34 (89%)
6534 (89%)35 (92%)
7534 (89%)35 (92%)
8532 (84%)33 (87%)

Across all 170 studies, recruiting or not: 21% stop at 75 or younger and 14% at 65; 36% take children; 3% are for women only and 2% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vasculitis studies take

Of 16 phase 3 interventional studies under Vasculitis, half reached primary completion within 67 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 367 mo42–120 · 16 studies——
Observational60 mo30–164 · 40 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 170. Browse all 170 → or search them.